Veradermics Analyst Price Targets - Benzinga

Veradermics Inc

MANENYSE

Trade with Public

Trade with Public

$115.72

-0.06-0.05%

近くで: Sep 24, 5:00 PM EST

$115.65

-0.07-0.06%

時間外: 9:30 AM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Veradermics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Veradermics (MANE).

Price Target Range — 3 Quarters

Analyst Consensus — 7 Analysts

7Buy

Consensus RatingBuy# Analysts7Avg. Consensus PT$150Upside to Avg. PT+29.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 16, 2026	Citigroup	Geoff Meacham	PT Raise	Buy	$135→$160
Jul 15, 2026	Needham	Serge Belanger	PT Raise	Buy	$136→$164
Jul 15, 2026	B. Riley Securities	Mayank Mamtani	Initiate	Buy	$170
Jul 7, 2026	Jefferies	Roger Song	PT Raise	Buy	$138→$182
Jun 16, 2026	LifeSci Capital	Rami Katkhuda	Initiate	Outperform	$135
Jun 2, 2026	Needham	Serge Belanger	Initiate	Buy	$136
May 18, 2026	Citigroup	Geoff Meacham	PT Raise	Buy	$120→$135
Apr 22, 2026	Leerink Partners	Marc Goodman	PT Raise	Outperform	$75→$90
Mar 2, 2026	Cantor Fitzgerald	Prakhar Agrawal	Initiate	Overweight	—
Mar 2, 2026	Citigroup	Geoff Meacham	Initiate	Buy	$85
Mar 2, 2026	Leerink Partners	Marc Goodman	Initiate	Outperform	$75
Mar 2, 2026	Jefferies	Roger Song	Initiate	Buy	$75

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Citigroup Maintains Buy on Veradermics, Raises Price Target to $160

Citigroup analyst Geoff Meacham maintains Veradermics (NYSE:MANE) with a Buy and raises the price target from $135 to $160.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Veradermics, Raises Price Target to $164

Needham analyst Serge Belanger maintains Veradermics (NYSE:MANE) with a Buy and raises the price target from $136 to $164.

Benzinga Newsdesk

PRO
B. Riley Securities Initiates Coverage On Veradermics with Buy Rating, Announces Price Target of $170

B. Riley Securities analyst Mayank Mamtani initiates coverage on Veradermics (NYSE:MANE) with a Buy rating and announces Price Target of $170.

Benzinga Newsdesk

PRO
Jefferies Maintains Buy on Veradermics, Raises Price Target to $182

Jefferies analyst Roger Song maintains Veradermics (NYSE:MANE) with a Buy and raises the price target from $138 to $182.

Benzinga Newsdesk

PRO
LifeSci Capital Initiates Coverage On Veradermics with Outperform Rating, Announces Price Target of $135

LifeSci Capital analyst Rami Katkhuda initiates coverage on Veradermics (NYSE:MANE) with a Outperform rating and announces Price Target of $135.

Benzinga Newsdesk

This Oppenheimer Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Wall Street analysts changed outlook on top names: ODTX, MOBI, MANE. See analyst ratings page for all changes. MOBI target prices: $16, $19, $31

Avi Kapoor